METHOTREXATE SODIUM

METHOTREXATE SODIUM was reported 487634 times

METHOTREXATE SODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 6217 0.8668
1 RHEUMATOID FACTOR POSITIVE 4904 0.8481
2 SWOLLEN JOINT COUNT INCREASED 2557 0.8011
3 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 534 0.7994
4 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 1802 0.7814
5 SYNOVITIS 13698 0.7589
6 PEMPHIGUS 9487 0.7581
7 RHEUMATIC FEVER 3354 0.7517
8 C-REACTIVE PROTEIN ABNORMAL 4719 0.7349
9 LUPUS VULGARIS 920 0.7302
10 DEEP VEIN THROMBOSIS POSTOPERATIVE 1414 0.7059
11 DUODENAL ULCER PERFORATION 5173 0.6949
12 HAND DEFORMITY 8996 0.6852
13 C-REACTIVE PROTEIN 629 0.6785
14 EPSTEIN BARR VIRUS POSITIVE MUCOCUTANEOUS ULCER 324 0.6585
15 GRANULOMA SKIN 539 0.6565
16 RHEUMATOID NODULE 1762 0.6391
17 FACET JOINT SYNDROME 2048 0.6284
18 BONE EROSION 2108 0.5955
19 X-RAY ABNORMAL 1057 0.5905
20 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1156 0.5574
21 DISLOCATION OF VERTEBRA 1261 0.5523
22 BODY HEIGHT BELOW NORMAL 344 0.5350
23 MUSCLE INJURY 4395 0.5299
24 HELICOBACTER INFECTION 5382 0.5231
25 LYMPHOPROLIFERATIVE DISORDER 1519 0.5167
26 SERONEGATIVE ARTHRITIS 581 0.5070
27 ENTHESOPATHY 781 0.4990
28 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 3232 0.4972
29 FOLLICULITIS 5151 0.4907
30 RETINITIS 832 0.4812
31 DACTYLITIS 471 0.4796
32 CONTRAINDICATED PRODUCT ADMINISTERED 14354 0.4736
33 RHEUMATOID LUNG 451 0.4723
34 DRUG CLEARANCE DECREASED 586 0.4484
35 JOINT DESTRUCTION 693 0.4454
36 PERICARDITIS 6979 0.4150
37 PERIPHERAL VENOUS DISEASE 1689 0.4132
38 BLOOD PARATHYROID HORMONE DECREASED 609 0.4107
39 BLOOD PRESSURE DIASTOLIC ABNORMAL 1031 0.4049
40 BLOOD PRESSURE SYSTOLIC ABNORMAL 992 0.4010
41 GLOSSODYNIA 8875 0.3960
42 TENOSYNOVITIS 1090 0.3948
43 JUVENILE IDIOPATHIC ARTHRITIS 966 0.3946
44 RED BLOOD CELL SEDIMENTATION RATE INCREASED 4336 0.3915
45 DRUG TOLERANCE DECREASED 1063 0.3782
46 RHEUMATOID ARTHRITIS 42800 0.3766
47 BLOOD IRON ABNORMAL 356 0.3644
48 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 626 0.3539
49 GRIP STRENGTH DECREASED 3052 0.3464
50 ACUTE GRAFT VERSUS HOST DISEASE 1583 0.3455
51 CHRONIC GRAFT VERSUS HOST DISEASE 1232 0.3409
52 PANNICULITIS 809 0.3340
53 JOINT RANGE OF MOTION DECREASED 4445 0.3311
54 ARTHRODESIS 335 0.3291
55 HYPOFIBRINOGENAEMIA 326 0.3286
56 SYSTEMIC LUPUS ERYTHEMATOSUS 11519 0.3242
57 FINGER DEFORMITY 1565 0.3227
58 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 884 0.3195
59 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 430 0.3043
60 WOUND 8368 0.2991
61 PSORIATIC ARTHROPATHY 11108 0.2734
62 HISTOPLASMOSIS DISSEMINATED 432 0.2720
63 LEUKOENCEPHALOPATHY 1011 0.2712
64 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 357 0.2711
65 SECONDARY IMMUNODEFICIENCY 321 0.2642
66 ARTHROPATHY 14675 0.2638
67 CENTRAL NERVOUS SYSTEM LYMPHOMA 361 0.2618
68 BREAST CANCER STAGE III 1679 0.2590
69 BURSITIS 3130 0.2577
70 MYELOPATHY 489 0.2572
71 POLYARTHRITIS 1338 0.2536
72 DRUG INTOLERANCE 24515 0.2535
73 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 540 0.2535
74 FOOT DEFORMITY 2808 0.2531
75 IRRITABLE BOWEL SYNDROME 5320 0.2479
76 ONYCHOMADESIS 1030 0.2452
77 THERAPEUTIC PRODUCT EFFECT DECREASED 10855 0.2421
78 FIBROMYALGIA 5757 0.2366
79 WOUND INFECTION 2576 0.2350
80 ONYCHOMYCOSIS 1031 0.2347
81 DRUG SPECIFIC ANTIBODY 317 0.2314
82 HYPERCHOLESTEROLAEMIA 2202 0.2278
83 FEBRILE BONE MARROW APLASIA 961 0.2259
84 GRAFT VERSUS HOST DISEASE IN SKIN 497 0.2254
85 SACROILIITIS 425 0.2250
86 LIP DRY 2034 0.2237
87 C-REACTIVE PROTEIN INCREASED 8140 0.2235
88 PSEUDOMONAL SEPSIS 390 0.2225
89 JOINT ARTHROPLASTY 398 0.2221
90 JOINT EFFUSION 1498 0.2170
91 TUBERCULIN TEST POSITIVE 549 0.2167
92 SCLERITIS 342 0.2133
93 CYTOMEGALOVIRUS CHORIORETINITIS 410 0.2100
94 TREATMENT FAILURE 17339 0.2091
95 PULMONARY FIBROSIS 3998 0.2082
96 IMPAIRED HEALING 6829 0.2078
97 JOINT SWELLING 24995 0.2069
98 SYNOVIAL CYST 955 0.2066
99 PUSTULAR PSORIASIS 693 0.2016
100 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 519 0.2009
101 OSTEOARTHRITIS 8429 0.1986
102 VENOOCCLUSIVE LIVER DISEASE 976 0.1975
103 LIVER FUNCTION TEST INCREASED 4229 0.1968
104 ANTIBODY TEST POSITIVE 322 0.1939
105 HUMAN HERPESVIRUS 6 INFECTION 365 0.1929
106 ARTHRITIS BACTERIAL 786 0.1913
107 GRAFT VERSUS HOST DISEASE 1371 0.1905
108 LOWER RESPIRATORY TRACT INFECTION 8383 0.1841
109 LIVER INJURY 4489 0.1827
110 MUCOSAL INFLAMMATION 4742 0.1809
111 HEPATIC ENZYME INCREASED 12320 0.1805
112 DIFFUSE LARGE B-CELL LYMPHOMA 1377 0.1785
113 EXOSTOSIS 1627 0.1780
114 AUTOIMMUNE DISORDER 1687 0.1729
115 EPSTEIN-BARR VIRUS INFECTION 1079 0.1725
116 DISSEMINATED TUBERCULOSIS 437 0.1702
117 LIVE BIRTH 1422 0.1698
118 NAIL DISORDER 1482 0.1692
119 MUSCULOSKELETAL STIFFNESS 14834 0.1692
120 LATENT TUBERCULOSIS 353 0.1684
121 VENOOCCLUSIVE DISEASE 422 0.1684
122 INFUSION RELATED REACTION 11157 0.1682
123 ALANINE AMINOTRANSFERASE ABNORMAL 354 0.1677
124 KNEE ARTHROPLASTY 3500 0.1661
125 SCIATICA 2648 0.1659
126 CYTOMEGALOVIRUS INFECTION REACTIVATION 728 0.1646
127 HIP ARTHROPLASTY 2520 0.1644
128 BLEPHAROSPASM 1036 0.1644
129 BLOOD PRESSURE DIASTOLIC DECREASED 1210 0.1638
130 CYSTITIS HAEMORRHAGIC 651 0.1613
131 HEPATIC FIBROSIS 553 0.1610
132 ADENOVIRUS INFECTION 467 0.1609
133 MOUTH ULCERATION 3390 0.1607
134 JOINT STIFFNESS 4201 0.1600
135 FAECAL CALPROTECTIN INCREASED 501 0.1580
136 PNEUMOCYSTIS JIROVECI PNEUMONIA 352 0.1578
137 NODULE 2060 0.1577
138 LUPUS-LIKE SYNDROME 1422 0.1566
139 SHOULDER ARTHROPLASTY 418 0.1550
140 SPINAL STENOSIS 639 0.1546
141 PNEUMOCYSTIS JIROVECII PNEUMONIA 1554 0.1546
142 B-CELL LYMPHOMA 525 0.1544
143 OBESITY 2458 0.1541
144 INFLAMMATION 7939 0.1537
145 STOMATITIS 9305 0.1533
146 BLOOD PRESSURE DIASTOLIC INCREASED 694 0.1502
147 PULMONARY TUBERCULOSIS 635 0.1485
148 HISTIOCYTOSIS HAEMATOPHAGIC 439 0.1477
149 ASPERGILLUS INFECTION 965 0.1469
150 FINE MOTOR SKILL DYSFUNCTION 424 0.1464
151 SWELLING 13709 0.1463
152 CUSHINGOID 469 0.1460
153 SKIN NECROSIS 755 0.1454
154 INFLAMMATORY MARKER INCREASED 721 0.1453
155 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 343 0.1444
156 UVEITIS 1960 0.1444
157 JOINT DISLOCATION 1526 0.1442
158 CYTOMEGALOVIRUS VIRAEMIA 638 0.1433
159 ANKYLOSING SPONDYLITIS 1889 0.1432
160 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 315 0.1427
161 DEMYELINATION 579 0.1412
162 CHONDROPATHY 380 0.1402
163 SARCOIDOSIS 666 0.1401
164 BASAL CELL CARCINOMA 2187 0.1400
165 SENSITIVITY TO WEATHER CHANGE 734 0.1394
166 INFUSION SITE REACTION 411 0.1375
167 TYPE 2 DIABETES MELLITUS 4625 0.1372
168 ARTHRITIS INFECTIVE 634 0.1365
169 BK VIRUS INFECTION 456 0.1351
170 DERMATOMYOSITIS 337 0.1329
171 SPONDYLITIS 476 0.1308
172 BLOOD PRESSURE SYSTOLIC INCREASED 2551 0.1307
173 WALKING AID USER 862 0.1306
174 IMMUNOSUPPRESSION 1146 0.1298
175 PNEUMONIA VIRAL 414 0.1297
176 ARTHRITIS 10071 0.1279
177 PULMONARY TOXICITY 903 0.1276
178 ANTINUCLEAR ANTIBODY POSITIVE 414 0.1273
179 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 6097 0.1268
180 PANCYTOPENIA 7082 0.1266
181 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1202 0.1258
182 MOBILITY DECREASED 8939 0.1243
183 MUSCULOSKELETAL PAIN 6423 0.1225
184 DISCOMFORT 7465 0.1222
185 BRONCHIECTASIS 821 0.1217
186 FEBRILE NEUTROPENIA 8023 0.1208
187 MATERNAL EXPOSURE TIMING UNSPECIFIED 447 0.1189
188 HEPATIC ENZYME ABNORMAL 588 0.1178
189 FOOT OPERATION 581 0.1173
190 BODY TEMPERATURE DECREASED 1145 0.1162
191 BLISTER 6532 0.1162
192 ACUTE LYMPHOCYTIC LEUKAEMIA 328 0.1157
193 BACK INJURY 1259 0.1157
194 IMMUNODEFICIENCY 1722 0.1154
195 STAPHYLOCOCCAL SEPSIS 568 0.1149
196 GAIT INABILITY 3824 0.1143
197 BLOOD PRESSURE FLUCTUATION 2740 0.1140
198 HEPATIC CIRRHOSIS 2142 0.1139
199 APHTHOUS ULCER 883 0.1137
200 GRANULOMA 393 0.1134
201 TENDERNESS 1183 0.1134
202 BLOOD CHOLESTEROL INCREASED 5258 0.1127
203 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 845 0.1125
204 SINUSITIS 11523 0.1123
205 INJECTION SITE HAEMATOMA 1629 0.1122
206 BLOOD CULTURE POSITIVE 336 0.1121
207 PULMONARY MASS 1670 0.1120
208 LUNG ADENOCARCINOMA 335 0.1112
209 BRONCHOPULMONARY ASPERGILLOSIS 862 0.1111
210 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 7869 0.1105
211 HEPATOTOXICITY 2461 0.1104
212 CREPITATIONS 324 0.1087
213 IRITIS 329 0.1081
214 LOWER LIMB FRACTURE 2077 0.1080
215 HEPATIC STEATOSIS 2001 0.1073
216 APPARENT DEATH 384 0.1065
217 HEPATITIS B REACTIVATION 338 0.1064
218 INFECTION 15332 0.1058
219 SKIN ULCER 2738 0.1058
220 INJECTION SITE IRRITATION 1339 0.1051
221 NIGHT SWEATS 3350 0.1039
222 ANAL FISSURE 555 0.1034
223 HERPES SIMPLEX 669 0.1028
224 DRUG TOLERANCE 520 0.1027
225 HAEMATOTOXICITY 976 0.1026
226 PHARYNGITIS 1272 0.1024
227 DRUG EFFECT INCOMPLETE 3716 0.1022
228 PYODERMA GANGRENOSUM 365 0.1014
229 GASTROINTESTINAL DISORDER 9065 0.1011
230 PLEURISY 600 0.1009
231 BACTERIAL SEPSIS 329 0.1009
232 SKIN PLAQUE 841 0.0996
233 LUNG DISORDER 4832 0.0985
234 PRODUCT LABEL CONFUSION 571 0.0979
235 ARTHRALGIA 40722 0.0978
236 PERIPHERAL SWELLING 15044 0.0976
237 ABDOMINAL DISCOMFORT 16285 0.0970
238 EAR PAIN 1886 0.0969
239 BONE MARROW FAILURE 1963 0.0965
240 IMMOBILE 419 0.0959
241 LIVER DISORDER 4247 0.0957
242 STAPHYLOCOCCAL BACTERAEMIA 416 0.0956
243 CYTOMEGALOVIRUS INFECTION 1587 0.0954
244 COELIAC DISEASE 932 0.0949
245 CYTOPENIA 1160 0.0946
246 NEUROTOXICITY 1655 0.0944
247 GASTROINTESTINAL TOXICITY 453 0.0942
248 INTENTIONAL PRODUCT USE ISSUE 8230 0.0939
249 TONSILLITIS 486 0.0930
250 PNEUMONIA FUNGAL 366 0.0927
251 THERAPY NON-RESPONDER 4168 0.0926
252 ULCER HAEMORRHAGE 624 0.0921
253 PRESCRIBED OVERDOSE 1783 0.0920
254 ANAL FISTULA 490 0.0917
255 WHEELCHAIR USER 407 0.0915
256 ANAL ABSCESS 493 0.0914
257 FEAR OF INJECTION 651 0.0912
258 ERYTHEMA NODOSUM 320 0.0911
259 DIVERTICULITIS 2526 0.0911
260 VIRAL UPPER RESPIRATORY TRACT INFECTION 433 0.0910
261 SPINAL OSTEOARTHRITIS 797 0.0906
262 LYMPHOMA 1401 0.0906
263 ULCER 1442 0.0905
264 DRUG SPECIFIC ANTIBODY PRESENT 586 0.0900
265 HYPERTRIGLYCERIDAEMIA 525 0.0896
266 ABSCESS LIMB 381 0.0893
267 THROMBOTIC MICROANGIOPATHY 870 0.0892
268 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 453 0.0889
269 CHRONIC SINUSITIS 334 0.0889
270 RASH VESICULAR 429 0.0886
271 OESOPHAGEAL CANDIDIASIS 353 0.0885
272 PSORIASIS 11563 0.0884
273 HEPATITIS 2264 0.0884
274 DEFORMITY 827 0.0884
275 ALOPECIA 17358 0.0883
276 OSTEOPOROSIS 3634 0.0883
277 ILL-DEFINED DISORDER 5363 0.0882
278 POSTOPERATIVE WOUND INFECTION 596 0.0882
279 HYPERTRANSAMINASAEMIA 608 0.0873
280 HERPES ZOSTER 5001 0.0869
281 INTERVERTEBRAL DISC DEGENERATION 804 0.0868
282 RHINOVIRUS INFECTION 338 0.0868
283 ORAL HERPES 1692 0.0866
284 EAR INFECTION 2306 0.0866
285 SKIN PAPILLOMA 346 0.0862
286 TOOTH ABSCESS 877 0.0860
287 NEUTROPENIC SEPSIS 613 0.0857
288 ESCHERICHIA URINARY TRACT INFECTION 364 0.0855
289 SPINAL FUSION SURGERY 346 0.0852
290 RED CELL DISTRIBUTION WIDTH INCREASED 353 0.0849
291 NASOPHARYNGITIS 15603 0.0846
292 SUSPECTED OFF LABEL USE 382 0.0845
293 SINUS CONGESTION 1138 0.0841
294 TIBIA FRACTURE 393 0.0837
295 MUSCULOSKELETAL DISORDER 1592 0.0836
296 MENISCUS INJURY 511 0.0830
297 TOOTH INFECTION 1095 0.0830
298 HYPOGAMMAGLOBULINAEMIA 541 0.0823
299 CARPAL TUNNEL SYNDROME 1153 0.0822
300 SPINAL PAIN 960 0.0818
301 JOINT INJURY 1749 0.0818
302 LOCALISED INFECTION 1977 0.0817
303 HYPERCALCAEMIA 1000 0.0809
304 MATERNAL EXPOSURE DURING PREGNANCY 7211 0.0808
305 SEPTIC SHOCK 3508 0.0805
306 POST PROCEDURAL INFECTION 654 0.0803
307 POOR VENOUS ACCESS 832 0.0803
308 ENCEPHALITIS 555 0.0801
309 INTERSTITIAL LUNG DISEASE 3877 0.0800
310 SQUAMOUS CELL CARCINOMA 753 0.0799
311 LUNG NEOPLASM 340 0.0795
312 CONDITION AGGRAVATED 23999 0.0789
313 DRUG ERUPTION 1396 0.0787
314 VASCULITIS 910 0.0780
315 MYELODYSPLASTIC SYNDROME 1128 0.0779
316 DRUG LEVEL BELOW THERAPEUTIC 430 0.0779
317 ORGANISING PNEUMONIA 386 0.0778
318 ENTEROCOCCAL INFECTION 376 0.0777
319 HYPERBILIRUBINAEMIA 806 0.0777
320 ADVERSE REACTION 1031 0.0777
321 NECK PAIN 4344 0.0776
322 SKIN LESION 2114 0.0770
323 BACTERIAL INFECTION 1437 0.0769
324 SUBCUTANEOUS ABSCESS 369 0.0769
325 ADRENAL INSUFFICIENCY 934 0.0769
326 RHINITIS 620 0.0768
327 RESPIRATORY TRACT CONGESTION 1219 0.0766
328 MUSCLE SPASTICITY 942 0.0766
329 UPPER RESPIRATORY TRACT INFECTION 3539 0.0765
330 ROTATOR CUFF SYNDROME 982 0.0764
331 CYST 945 0.0761
332 DISABILITY 1501 0.0758
333 KLEBSIELLA INFECTION 383 0.0757
334 CLOSTRIDIUM DIFFICILE COLITIS 794 0.0748
335 ABSCESS 1191 0.0746
336 PRESCRIBED UNDERDOSE 1480 0.0741
337 BREAST CANCER STAGE II 617 0.0741
338 BODY TEMPERATURE INCREASED 1513 0.0741
339 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 610 0.0739
340 SKIN INFECTION 828 0.0737
341 IRON DEFICIENCY 330 0.0733
342 BRONCHITIS 5424 0.0732
343 MALIGNANT MELANOMA 979 0.0730
344 ORAL DISORDER 533 0.0726
345 APLASTIC ANAEMIA 379 0.0725
346 INJECTION SITE WARMTH 1489 0.0723
347 LIVER FUNCTION TEST ABNORMAL 2104 0.0723
348 HERPES VIRUS INFECTION 416 0.0721
349 GENERAL PHYSICAL HEALTH DETERIORATION 8341 0.0720
350 PSEUDOMONAS INFECTION 617 0.0719
351 DRUG-INDUCED LIVER INJURY 2255 0.0718
352 NEPHROPATHY TOXIC 806 0.0717
353 STREPTOCOCCAL INFECTION 397 0.0713
354 MYOSITIS 640 0.0713
355 SLEEP DISORDER 5031 0.0712
356 HYPERSENSITIVITY 13205 0.0711
357 STRESS FRACTURE 383 0.0709
358 LEUKOPENIA 3546 0.0708
359 DRUG INEFFECTIVE 93088 0.0706
360 ENTERITIS 451 0.0704
361 TRANSAMINASES INCREASED 1562 0.0702
362 ACUTE MYELOID LEUKAEMIA 1092 0.0700
363 SPINAL COLUMN STENOSIS 329 0.0696
364 BACTERAEMIA 825 0.0694
365 HYPOALBUMINAEMIA 539 0.0693
366 HEART RATE DECREASED 2434 0.0692
367 PHARYNGOLARYNGEAL PAIN 368 0.0692
368 INTERVERTEBRAL DISC PROTRUSION 1512 0.0691
369 VAGINAL INFECTION 325 0.0690
370 CANDIDA INFECTION 1164 0.0689
371 ERYSIPELAS 346 0.0688
372 COLITIS MICROSCOPIC 326 0.0688
373 TENDON DISORDER 447 0.0685
374 OSTEOMYELITIS 1238 0.0683
375 CONTUSION 6578 0.0683
376 PAIN IN EXTREMITY 20029 0.0679
377 SPINAL DISORDER 639 0.0674
378 WHEEZING 3949 0.0665
379 RESPIRATORY TRACT INFECTION 1727 0.0662
380 HYPERKERATOSIS 365 0.0661
381 RESPIRATORY DISORDER 1976 0.0660
382 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1132 0.0660
383 CELLULITIS 3319 0.0658
384 STAPHYLOCOCCAL INFECTION 2172 0.0658
385 IMMUNE SYSTEM DISORDER 867 0.0657
386 THERAPEUTIC RESPONSE DECREASED 3985 0.0657
387 OSTEOPENIA 996 0.0656
388 LUNG INFILTRATION 579 0.0655
389 CYSTITIS 2077 0.0652
390 DYSLIPIDAEMIA 331 0.0651
391 INJECTION SITE REACTION 4484 0.0651
392 THERAPY PARTIAL RESPONDER 1016 0.0651
393 ACUTE RESPIRATORY DISTRESS SYNDROME 1149 0.0649
394 PNEUMONITIS 1766 0.0648
395 FOOT FRACTURE 1229 0.0648
396 ORAL CANDIDIASIS 850 0.0645
397 PAIN 39637 0.0645
398 PYELONEPHRITIS 557 0.0642
399 GASTROINTESTINAL INFECTION 575 0.0641
400 TENDONITIS 993 0.0641
401 LOCAL SWELLING 1116 0.0639
402 OEDEMA 3447 0.0635
403 CONGENITAL ANOMALY 490 0.0632
404 SEPSIS 7046 0.0631
405 ESCHERICHIA INFECTION 515 0.0625
406 FISTULA 702 0.0624
407 GASTROINTESTINAL INFLAMMATION 487 0.0621
408 ARTHROPOD BITE 459 0.0619
409 DERMATITIS ALLERGIC 775 0.0615
410 ROAD TRAFFIC ACCIDENT 2571 0.0614
411 DRUG EFFECT DECREASED 3298 0.0612
412 PHARYNGITIS STREPTOCOCCAL 661 0.0610
413 SKIN LACERATION 660 0.0606
414 IMPAIRED WORK ABILITY 1297 0.0606
415 MENINGITIS 405 0.0606
416 TENDON RUPTURE 748 0.0605
417 MUSCULOSKELETAL DISCOMFORT 1042 0.0605
418 TONGUE DISORDER 438 0.0605
419 SQUAMOUS CELL CARCINOMA OF SKIN 365 0.0604
420 CATARACT 3594 0.0603
421 ALANINE AMINOTRANSFERASE INCREASED 3701 0.0602
422 PNEUMONIA BACTERIAL 550 0.0599
423 GASTROENTERITIS 872 0.0597
424 VIRAL INFECTION 1985 0.0596
425 DIVERTICULUM 420 0.0590
426 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3237 0.0589
427 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1669 0.0589
428 SENSORY LOSS 470 0.0583
429 LUNG INFECTION 906 0.0583
430 INJECTION SITE PRURITUS 3897 0.0581
431 KIDNEY INFECTION 1141 0.0581
432 FREQUENT BOWEL MOVEMENTS 1570 0.0581
433 PELVIC FRACTURE 452 0.0580
434 ODYNOPHAGIA 346 0.0579
435 NERVE COMPRESSION 535 0.0579
436 SKIN MASS 387 0.0579
437 FUNGAL INFECTION 1931 0.0579
438 COVID-19 PNEUMONIA 684 0.0579
439 ATELECTASIS 555 0.0574
440 FURUNCLE 455 0.0574
441 SECOND PRIMARY MALIGNANCY 477 0.0573
442 DECREASED IMMUNE RESPONSIVENESS 561 0.0571
443 SPUTUM DISCOLOURED 542 0.0571
444 BONE DISORDER 1041 0.0571
445 HYPERTENSION 12096 0.0570
446 TOOTH FRACTURE 629 0.0570
447 LYMPHADENOPATHY 2011 0.0568
448 HEMIPARESIS 961 0.0567
449 PNEUMONIA 18361 0.0567
450 INJURY 3971 0.0564
451 LYMPHOPENIA 799 0.0564
452 RENAL CYST 448 0.0564
453 MYELOSUPPRESSION 2028 0.0562
454 TUMOUR LYSIS SYNDROME 495 0.0562
455 PRODUCT USE ISSUE 10566 0.0562
456 MASS 782 0.0559
457 EMPHYSEMA 563 0.0558
458 VITAMIN D DECREASED 472 0.0552
459 OROPHARYNGEAL PAIN 5111 0.0552
460 PYREXIA 19074 0.0551
461 SKIN ATROPHY 317 0.0550
462 UROSEPSIS 508 0.0550
463 SPINAL COMPRESSION FRACTURE 454 0.0549
464 HEPATOMEGALY 539 0.0548
465 DIARRHOEA HAEMORRHAGIC 510 0.0545
466 WEIGHT INCREASED 12127 0.0541
467 BREAST MASS 363 0.0540
468 ORAL PAIN 1206 0.0538
469 SECRETION DISCHARGE 664 0.0530
470 PULMONARY HAEMORRHAGE 413 0.0527
471 GLAUCOMA 1016 0.0527
472 RASH PUSTULAR 384 0.0527
473 GASTROINTESTINAL PAIN 577 0.0524
474 HEPATITIS B 314 0.0521
475 GINGIVAL PAIN 414 0.0520
476 MATERNAL EXPOSURE BEFORE PREGNANCY 355 0.0519
477 INFLUENZA 5794 0.0519
478 RASH 22586 0.0518
479 HYPOAESTHESIA 7745 0.0517
480 DRUG LEVEL DECREASED 525 0.0515
481 LIGAMENT SPRAIN 510 0.0515
482 DEVICE RELATED INFECTION 792 0.0514
483 PAPULE 362 0.0513
484 INJECTION SITE ERYTHEMA 6369 0.0513
485 PHOTOSENSITIVITY REACTION 846 0.0512
486 DISSEMINATED INTRAVASCULAR COAGULATION 721 0.0512
487 FACIAL PARALYSIS 436 0.0511
488 ENCEPHALOPATHY 1252 0.0509
489 DYSSTASIA 1485 0.0508
490 GAIT DISTURBANCE 9678 0.0505
491 MOTOR DYSFUNCTION 515 0.0505
492 ARTERIAL OCCLUSIVE DISEASE 396 0.0503
493 RHINORRHOEA 3254 0.0503
494 RESPIRATORY RATE INCREASED 446 0.0502
495 DRUG LEVEL INCREASED 830 0.0501
496 TASTE DISORDER 1016 0.0500
497 PRODUCTIVE COUGH 2390 0.0500
498 IRON DEFICIENCY ANAEMIA 462 0.0500
499 BACK DISORDER 811 0.0498
500 EPILEPSY 1521 0.0497
501 HIATUS HERNIA 643 0.0496
502 COLITIS 1882 0.0496
503 LIMB INJURY 1348 0.0496
504 DELIRIUM 1718 0.0495
505 LIMB DISCOMFORT 1530 0.0494
506 TOOTH DISORDER 1098 0.0493
507 HEPATOCELLULAR INJURY 700 0.0493
508 EYE INFECTION 557 0.0493
509 THROMBOCYTOPENIA 5513 0.0492
510 HEMIPLEGIA 409 0.0491
511 BLOOD TEST ABNORMAL 690 0.0491
512 NEPHROLITHIASIS 2252 0.0490
513 ANKLE FRACTURE 760 0.0490
514 POLYNEUROPATHY 587 0.0490
515 ASPARTATE AMINOTRANSFERASE INCREASED 2594 0.0488
516 INCREASED TENDENCY TO BRUISE 449 0.0488
517 HEPATIC CYTOLYSIS 619 0.0485
518 CLOSTRIDIUM DIFFICILE INFECTION 1057 0.0484
519 WEIGHT FLUCTUATION 505 0.0482
520 CARDIOTOXICITY 429 0.0480
521 MOUTH HAEMORRHAGE 351 0.0478
522 BLOOD IRON DECREASED 567 0.0477
523 INJECTION SITE INDURATION 617 0.0475
524 HAND FRACTURE 336 0.0474
525 INJECTION SITE SWELLING 3632 0.0474
526 BLOOD ALBUMIN DECREASED 373 0.0470
527 NEUTROPENIA 6387 0.0469
528 GROIN PAIN 412 0.0469
529 GASTRIC ULCER 890 0.0468
530 KNEE OPERATION 460 0.0467
531 INJECTION SITE PAIN 14337 0.0467
532 GASTROENTERITIS VIRAL 843 0.0466
533 OXYGEN SATURATION DECREASED 2612 0.0464
534 OFF LABEL USE 40572 0.0463
535 SKIN HAEMORRHAGE 686 0.0462
536 DRY MOUTH 3744 0.0461
537 URTICARIA 7717 0.0460
538 INJECTION SITE BRUISING 3660 0.0458
539 MULTI-ORGAN FAILURE 793 0.0458
540 UTERINE LEIOMYOMA 334 0.0456
541 GASTRIC DISORDER 1567 0.0456
542 DYSPEPSIA 4492 0.0456
543 PULMONARY THROMBOSIS 496 0.0454
544 MUSCULAR WEAKNESS 5131 0.0451
545 SKIN CANCER 972 0.0451
546 CARDIAC MURMUR 390 0.0450
547 MIGRAINE 4296 0.0450
548 SKIN REACTION 633 0.0449
549 VITAMIN D DEFICIENCY 438 0.0449
550 OVARIAN CYST 446 0.0446
551 COLITIS ULCERATIVE 1990 0.0445
552 COAGULOPATHY 740 0.0444
553 SKIN DISORDER 1470 0.0440
554 NERVE INJURY 490 0.0440
555 PLATELET COUNT INCREASED 574 0.0440
556 PRODUCT USE IN UNAPPROVED INDICATION 10892 0.0439
557 CONFUSIONAL STATE 7074 0.0437
558 BACK PAIN 10141 0.0436
559 BLOOD LACTATE DEHYDROGENASE INCREASED 691 0.0436
560 PLEURAL EFFUSION 2647 0.0435
561 RESPIRATORY FAILURE 3171 0.0434
562 MUSCULOSKELETAL CHEST PAIN 673 0.0434
563 PNEUMOTHORAX 689 0.0434
564 EYE INFLAMMATION 414 0.0433
565 DISEASE RECURRENCE 2056 0.0432
566 PREGNANCY 864 0.0431
567 HEPATIC FUNCTION ABNORMAL 1606 0.0430
568 EXPOSURE DURING PREGNANCY 2672 0.0429
569 DENTAL CARIES 473 0.0427
570 TOOTHACHE 773 0.0427
571 OEDEMA PERIPHERAL 5191 0.0425
572 URINARY TRACT INFECTION 7263 0.0425
573 SCAB 484 0.0424
574 FATIGUE 33027 0.0424
575 INJECTION SITE RASH 1299 0.0423
576 NASAL CONGESTION 2485 0.0422
577 COUGH 11840 0.0422
578 HERNIA 816 0.0422
579 AORTIC ANEURYSM 321 0.0421
580 HAEMATOCHEZIA 2322 0.0420
581 SINUS DISORDER 833 0.0420
582 SPLENOMEGALY 492 0.0420
583 GASTRITIS 1105 0.0419
584 APPENDICITIS 392 0.0419
585 AGRANULOCYTOSIS 780 0.0419
586 FEMUR FRACTURE 1298 0.0419
587 INJECTION SITE DISCOLOURATION 523 0.0418
588 THERAPEUTIC RESPONSE SHORTENED 1387 0.0418
589 WRIST FRACTURE 501 0.0418
590 RASH PRURITIC 2255 0.0416
591 ADVERSE DRUG REACTION 3735 0.0415
592 BEDRIDDEN 542 0.0412
593 INTESTINAL PERFORATION 461 0.0410
594 BLOOD PRESSURE INCREASED 6273 0.0410
595 IMPAIRED QUALITY OF LIFE 589 0.0409
596 ANAPHYLACTIC REACTION 2263 0.0409
597 PULMONARY CONGESTION 539 0.0408
598 WEIGHT DECREASED 11375 0.0407
599 INJECTION SITE EXTRAVASATION 502 0.0406
600 ABDOMINAL PAIN 9403 0.0404
601 UPPER LIMB FRACTURE 803 0.0403
602 MYOPATHY 348 0.0402
603 INJECTION SITE URTICARIA 985 0.0401
604 MUSCLE STRAIN 345 0.0398
605 EYE DISORDER 1307 0.0397
606 MALAISE 17406 0.0396
607 POST PROCEDURAL COMPLICATION 759 0.0395
608 WHITE BLOOD CELL COUNT INCREASED 1515 0.0394
609 RECTAL HAEMORRHAGE 1690 0.0393
610 GASTROOESOPHAGEAL REFLUX DISEASE 3164 0.0393
611 HIDRADENITIS 358 0.0392
612 ABDOMINAL PAIN UPPER 8061 0.0391
613 DRUG RESISTANCE 997 0.0388
614 DEAFNESS 1011 0.0386
615 THYROID DISORDER 594 0.0385
616 PERICARDIAL EFFUSION 889 0.0384
617 AFFECT LABILITY 370 0.0384
618 CHOLELITHIASIS 1260 0.0384
619 LACERATION 361 0.0383
620 MOVEMENT DISORDER 1227 0.0382
621 SMALL INTESTINAL OBSTRUCTION 470 0.0381
622 PANCREATITIS 2017 0.0381
623 FRACTURE 719 0.0379
624 DIABETES MELLITUS 2895 0.0379
625 RIB FRACTURE 775 0.0376
626 INFLAMMATORY BOWEL DISEASE 368 0.0376
627 HYPERTENSIVE CRISIS 418 0.0375
628 NEURALGIA 911 0.0374
629 HEADACHE 23450 0.0374
630 VOMITING 17576 0.0373
631 SPINAL FRACTURE 749 0.0373
632 CHOLECYSTITIS 444 0.0372
633 RESPIRATORY SYNCYTIAL VIRUS INFECTION 322 0.0369
634 HYSTERECTOMY 320 0.0369
635 PAIN IN JAW 1046 0.0369
636 CONJUNCTIVITIS 682 0.0367
637 NAUSEA 28919 0.0365
638 HYPOPHAGIA 932 0.0364
639 HAEMORRHOIDS 707 0.0362
640 TOOTH EXTRACTION 451 0.0362
641 MEDICATION ERROR 2009 0.0361
642 ASTHMA 4080 0.0361
643 BLOOD BILIRUBIN INCREASED 973 0.0360
644 SCRATCH 377 0.0357
645 COLON CANCER 532 0.0357
646 HEART RATE IRREGULAR 806 0.0356
647 PETECHIAE 372 0.0356
648 DRY EYE 1774 0.0355
649 OESOPHAGITIS 387 0.0354
650 ANAEMIA 6751 0.0354
651 CHOLESTASIS 679 0.0353
652 HAEMATOCRIT DECREASED 701 0.0353
653 CHEST PAIN 6544 0.0353
654 FLANK PAIN 331 0.0353
655 ACUTE RESPIRATORY FAILURE 679 0.0353
656 INJECTION SITE HAEMORRHAGE 2808 0.0351
657 DERMATITIS 734 0.0350
658 SNEEZING 785 0.0350
659 PHOTOPHOBIA 658 0.0349
660 PARAESTHESIA 5493 0.0349
661 QUALITY OF LIFE DECREASED 468 0.0348
662 COVID-19 6102 0.0347
663 EATING DISORDER 738 0.0346
664 BRAIN OEDEMA 437 0.0346
665 AMNESIA 2235 0.0343
666 OSTEONECROSIS 1121 0.0341
667 NEOPLASM 392 0.0341
668 SLEEP APNOEA SYNDROME 649 0.0340
669 ASCITES 995 0.0338
670 ADVERSE EVENT 3110 0.0337
671 ACCIDENT 401 0.0335
672 ANGINA PECTORIS 962 0.0335
673 RENAL IMPAIRMENT 2820 0.0335
674 DEEP VEIN THROMBOSIS 2180 0.0335
675 TOXIC EPIDERMAL NECROLYSIS 509 0.0335
676 CORONARY ARTERY OCCLUSION 456 0.0332
677 MITRAL VALVE INCOMPETENCE 376 0.0332
678 GAMMA-GLUTAMYLTRANSFERASE INCREASED 734 0.0331
679 HYPOKINESIA 479 0.0330
680 SEASONAL ALLERGY 467 0.0330
681 MALNUTRITION 369 0.0329
682 INFLUENZA LIKE ILLNESS 2708 0.0329
683 SPINAL OPERATION 405 0.0328
684 DISEASE PROGRESSION 3883 0.0328
685 REBOUND EFFECT 370 0.0327
686 BLOOD CREATININE INCREASED 2137 0.0327
687 APHASIA 988 0.0327
688 HEPATIC FAILURE 986 0.0327
689 GALLBLADDER DISORDER 583 0.0326
690 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5866 0.0325
691 BODY HEIGHT DECREASED 348 0.0325
692 PRURITUS 12485 0.0325
693 DIARRHOEA 20900 0.0323
694 FEEDING DISORDER 655 0.0323
695 TOXICITY TO VARIOUS AGENTS 5444 0.0323
696 CHOLECYSTECTOMY 367 0.0321
697 PULMONARY EMBOLISM 3021 0.0318
698 ASTHENIA 11934 0.0317
699 SCAR 542 0.0316
700 FALL 10533 0.0316
701 WHITE BLOOD CELL COUNT DECREASED 3428 0.0316
702 FEELING HOT 1931 0.0315
703 RESPIRATORY DISTRESS 868 0.0314
704 APHONIA 434 0.0311
705 EAR DISCOMFORT 319 0.0310
706 NEUTROPHIL COUNT INCREASED 318 0.0310
707 HYPERLIPIDAEMIA 371 0.0310
708 HAEMOGLOBIN DECREASED 3171 0.0309
709 OBSTRUCTIVE AIRWAYS DISORDER 343 0.0308
710 PANCREATITIS ACUTE 690 0.0307
711 NEUTROPHIL COUNT DECREASED 1251 0.0307
712 GENERALISED OEDEMA 378 0.0305
713 SARS-COV-2 TEST POSITIVE 403 0.0305
714 ERYTHEMA 6221 0.0302
715 ILEUS 376 0.0302
716 INJECTION SITE NODULE 332 0.0301
717 RASH ERYTHEMATOUS 1437 0.0300
718 CARDIOMYOPATHY 444 0.0300
719 DEPRESSION 6831 0.0300
720 ACUTE KIDNEY INJURY 4581 0.0299
721 CHILLS 3496 0.0298
722 NO THERAPEUTIC RESPONSE 363 0.0297
723 INSOMNIA 7927 0.0297
724 CARDIOMEGALY 366 0.0297
725 MEMORY IMPAIRMENT 4088 0.0297
726 DECREASED APPETITE 6894 0.0297
727 POOR QUALITY SLEEP 637 0.0296
728 LABORATORY TEST ABNORMAL 873 0.0296
729 ATRIAL FIBRILLATION 2876 0.0295
730 GOUT 526 0.0293
731 RASH PAPULAR 657 0.0293
732 METASTASES TO LUNG 338 0.0292
733 NERVOUS SYSTEM DISORDER 911 0.0292
734 DRUG INTERACTION 4627 0.0291
735 RASH MACULO-PAPULAR 647 0.0291
736 DYSPNOEA 16434 0.0290
737 RED BLOOD CELL COUNT DECREASED 829 0.0290
738 HYPOKALAEMIA 1336 0.0289
739 ORAL DISCOMFORT 401 0.0288
740 DYSPNOEA EXERTIONAL 1086 0.0288
741 SKIN DISCOLOURATION 1321 0.0287
742 ILLNESS 2950 0.0286
743 LUNG NEOPLASM MALIGNANT 1176 0.0286
744 TACHYCARDIA 2542 0.0286
745 HYPOXIA 1004 0.0285
746 THROAT IRRITATION 1276 0.0284
747 DRUG TOXICITY 385 0.0282
748 ACUTE HEPATIC FAILURE 386 0.0282
749 TACHYPNOEA 381 0.0280
750 ABDOMINAL DISTENSION 2918 0.0279
751 ATAXIA 330 0.0278
752 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1448 0.0277
753 LYMPHOCYTE COUNT DECREASED 490 0.0277
754 BONE DENSITY DECREASED 862 0.0275
755 HYPOTHYROIDISM 878 0.0275
756 PHARYNGEAL OEDEMA 422 0.0274
757 MUSCLE SPASMS 5033 0.0274
758 INTESTINAL OBSTRUCTION 1032 0.0274
759 BLOOD URINE PRESENT 519 0.0273
760 RENAL DISORDER 1273 0.0273
761 EPISTAXIS 2034 0.0272
762 MACULAR DEGENERATION 323 0.0270
763 ELECTROLYTE IMBALANCE 314 0.0270
764 PULMONARY OEDEMA 1202 0.0268
765 RENAL FAILURE 3552 0.0267
766 PRODUCT PRESCRIBING ERROR 637 0.0267
767 ABASIA 658 0.0266
768 DYSPHONIA 1556 0.0266
769 PAIN OF SKIN 716 0.0266
770 GINGIVAL BLEEDING 363 0.0266
771 HYPOCALCAEMIA 500 0.0264
772 BLINDNESS UNILATERAL 372 0.0263
773 IMPAIRED GASTRIC EMPTYING 359 0.0263
774 HEART RATE INCREASED 2608 0.0263
775 SURGERY 1532 0.0261
776 PERIPHERAL COLDNESS 357 0.0260
777 VISUAL IMPAIRMENT 3219 0.0259
778 METASTASES TO LIVER 456 0.0259
779 VERTIGO 1578 0.0259
780 NEUROPATHY PERIPHERAL 2461 0.0258
781 CYTOKINE RELEASE SYNDROME 519 0.0258
782 ANOREXIA 333 0.0258
783 MUSCLE ATROPHY 327 0.0258
784 DYSARTHRIA 971 0.0258
785 SKIN FISSURES 504 0.0258
786 BURNING SENSATION 1807 0.0257
787 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 436 0.0256
788 COORDINATION ABNORMAL 358 0.0256
789 DYSURIA 944 0.0256
790 NEOPLASM MALIGNANT 1708 0.0256
791 LEUKOCYTOSIS 463 0.0256
792 BLOOD ALKALINE PHOSPHATASE INCREASED 634 0.0255
793 ACTIVITIES OF DAILY LIVING IMPAIRED 505 0.0255
794 PROCEDURAL PAIN 705 0.0254
795 ACCIDENTAL OVERDOSE 928 0.0253
796 THROMBOSIS 2039 0.0253
797 HAEMATURIA 859 0.0251
798 PALLOR 678 0.0249
799 EJECTION FRACTION DECREASED 387 0.0249
800 ABDOMINAL PAIN LOWER 627 0.0248
801 FEELING COLD 690 0.0248
802 PLATELET COUNT DECREASED 2635 0.0247
803 INTENTIONAL DOSE OMISSION 704 0.0247
804 TRANSIENT ISCHAEMIC ATTACK 833 0.0247
805 CEREBRAL INFARCTION 598 0.0245
806 HAEMOPTYSIS 679 0.0243
807 TUBULOINTERSTITIAL NEPHRITIS 456 0.0243
808 BLOOD PRESSURE ABNORMAL 483 0.0243
809 CHEST DISCOMFORT 2487 0.0243
810 PARALYSIS 345 0.0241
811 WRONG TECHNIQUE IN DRUG USAGE PROCESS 874 0.0240
812 RASH MACULAR 841 0.0240
813 CARDIAC FAILURE 1931 0.0240
814 SINUS TACHYCARDIA 340 0.0239
815 DIZZINESS 11926 0.0239
816 HIP FRACTURE 761 0.0236
817 DYSPHAGIA 2235 0.0235
818 RENAL FAILURE ACUTE 987 0.0232
819 CORONARY ARTERY DISEASE 703 0.0232
820 SWELLING FACE 1511 0.0232
821 HAEMATOMA 598 0.0231
822 PRURITUS GENERALISED 498 0.0230
823 MENTAL STATUS CHANGES 637 0.0229
824 BONE PAIN 1343 0.0229
825 DIPLOPIA 593 0.0228
826 PERITONITIS 471 0.0227
827 HYPOTENSION 4549 0.0227
828 SHOCK 521 0.0226
829 EOSINOPHILIA 391 0.0223
830 SENSORY DISTURBANCE 358 0.0223
831 SWOLLEN TONGUE 693 0.0222
832 PROTEINURIA 420 0.0221
833 SUBDURAL HAEMATOMA 316 0.0221
834 OSTEONECROSIS OF JAW 545 0.0220
835 FLUID RETENTION 1118 0.0220
836 BLOOD UREA INCREASED 368 0.0220
837 PULMONARY HYPERTENSION 457 0.0219
838 BLOOD TRIGLYCERIDES INCREASED 387 0.0219
839 MYALGIA 3723 0.0219
840 BLOOD POTASSIUM DECREASED 658 0.0219
841 URINARY INCONTINENCE 645 0.0217
842 BLOOD PRESSURE DECREASED 1437 0.0216
843 ACUTE MYOCARDIAL INFARCTION 636 0.0215
844 SKIN EXFOLIATION 1819 0.0215
845 LOSS OF CONSCIOUSNESS 2753 0.0215
846 BREAST CANCER 1994 0.0214
847 LACRIMATION INCREASED 644 0.0213
848 HAEMORRHAGE INTRACRANIAL 318 0.0212
849 HAEMATEMESIS 539 0.0212
850 HAEMORRHAGE 2209 0.0211
851 MULTIPLE FRACTURES 346 0.0210
852 TINNITUS 966 0.0210
853 HEAD DISCOMFORT 371 0.0209
854 EYE PAIN 1180 0.0209
855 BLINDNESS 846 0.0207
856 HYPERGLYCAEMIA 754 0.0207
857 MIDDLE INSOMNIA 386 0.0206
858 JAUNDICE 555 0.0206
859 DEVICE MALFUNCTION 1445 0.0205
860 FEELING ABNORMAL 4887 0.0204
861 UNDERDOSE 1453 0.0199
862 ANXIETY 5638 0.0198
863 LETHARGY 1133 0.0197
864 ARRHYTHMIA 931 0.0196
865 PRESYNCOPE 477 0.0196
866 SYNCOPE 1948 0.0194
867 PALPITATIONS 2280 0.0194
868 FACE OEDEMA 325 0.0193
869 ECZEMA 1004 0.0192
870 GENERALISED TONIC-CLONIC SEIZURE 317 0.0191
871 HEAD INJURY 602 0.0190
872 COLD SWEAT 335 0.0190
873 HYPERHIDROSIS 2436 0.0189
874 PRODUCT PRESCRIBING ISSUE 410 0.0188
875 THROAT TIGHTNESS 508 0.0188
876 ISCHAEMIC STROKE 333 0.0186
877 RASH GENERALISED 482 0.0186
878 RESTLESS LEGS SYNDROME 338 0.0186
879 ANAPHYLACTIC SHOCK 476 0.0184
880 GASTROINTESTINAL HAEMORRHAGE 1539 0.0184
881 DEHYDRATION 2441 0.0183
882 UNEVALUABLE EVENT 1371 0.0181
883 BLOOD SODIUM DECREASED 340 0.0180
884 POLLAKIURIA 746 0.0179
885 DEPRESSED MOOD 943 0.0178
886 CEREBRAL HAEMORRHAGE 634 0.0177
887 INCORRECT DOSE ADMINISTERED 4038 0.0177
888 INJECTION SITE MASS 653 0.0176
889 FAECES DISCOLOURED 382 0.0176
890 MELAENA 387 0.0176
891 MYOCARDIAL INFARCTION 3059 0.0175
892 OCULAR HYPERAEMIA 820 0.0173
893 HYPERSOMNIA 493 0.0172
894 TREATMENT NONCOMPLIANCE 937 0.0171
895 HYPONATRAEMIA 960 0.0170
896 HYPOACUSIS 732 0.0170
897 VISUAL ACUITY REDUCED 556 0.0167
898 NEEDLE ISSUE 487 0.0167
899 NEOPLASM PROGRESSION 580 0.0167
900 URINARY RETENTION 554 0.0166
901 CEREBROVASCULAR ACCIDENT 2810 0.0166
902 TOOTH LOSS 343 0.0165
903 HOT FLUSH 1246 0.0165
904 CARDIAC FAILURE CONGESTIVE 1327 0.0165
905 LIP SWELLING 550 0.0165
906 SPEECH DISORDER 864 0.0165
907 CRYING 599 0.0165
908 EYE SWELLING 609 0.0164
909 PNEUMONIA ASPIRATION 408 0.0163
910 CARDIAC DISORDER 1527 0.0163
911 BALANCE DISORDER 1408 0.0163
912 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 474 0.0162
913 SEIZURE 1864 0.0161
914 NERVOUSNESS 840 0.0161
915 INTENTIONAL PRODUCT MISUSE 1385 0.0158
916 STEVENS-JOHNSON SYNDROME 351 0.0158
917 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1115 0.0157
918 CARDIOVASCULAR DISORDER 397 0.0156
919 BLOOD CREATINE PHOSPHOKINASE INCREASED 450 0.0156
920 ALTERED STATE OF CONSCIOUSNESS 338 0.0156
921 DRUG DOSE OMISSION 2555 0.0154
922 DEVICE ISSUE 1378 0.0153
923 METABOLIC ACIDOSIS 490 0.0153
924 ANGIOEDEMA 674 0.0152
925 FLATULENCE 862 0.0152
926 VISION BLURRED 2073 0.0151
927 CONVULSION 853 0.0149
928 RETCHING 315 0.0148
929 ACNE 1118 0.0147
930 SOMNOLENCE 2962 0.0147
931 DEMENTIA 410 0.0147
932 COMA 697 0.0146
933 THERAPEUTIC RESPONSE UNEXPECTED 654 0.0146
934 MENTAL DISORDER 630 0.0145
935 CHRONIC KIDNEY DISEASE 1087 0.0143
936 DISORIENTATION 564 0.0142
937 EYE PRURITUS 476 0.0142
938 BREAST CANCER FEMALE 376 0.0141
939 ABORTION SPONTANEOUS 558 0.0139
940 CARDIAC ARREST 1145 0.0139
941 TREMOR 2297 0.0138
942 PRODUCT DOSE OMISSION IN ERROR 388 0.0137
943 CONSTIPATION 2959 0.0136
944 COGNITIVE DISORDER 633 0.0135
945 EMOTIONAL DISORDER 411 0.0133
946 PANIC ATTACK 484 0.0133
947 PRODUCT DOSE OMISSION 859 0.0131
948 FLUSHING 1302 0.0128
949 MALIGNANT NEOPLASM PROGRESSION 1299 0.0127
950 THERAPY INTERRUPTED 889 0.0124
951 VAGINAL HAEMORRHAGE 536 0.0123
952 UNRESPONSIVE TO STIMULI 318 0.0123
953 HYPOGLYCAEMIA 594 0.0122
954 DEPRESSED LEVEL OF CONSCIOUSNESS 484 0.0122
955 MOOD SWINGS 387 0.0121
956 CARDIO-RESPIRATORY ARREST 504 0.0120
957 FEAR 318 0.0118
958 DYSGEUSIA 875 0.0118
959 PRODUCT DOSE OMISSION ISSUE 3350 0.0114
960 FOETAL EXPOSURE DURING PREGNANCY 905 0.0111
961 PROSTATE CANCER 887 0.0110
962 DRY SKIN 1467 0.0110
963 THERAPY CESSATION 564 0.0110
964 PSYCHOTIC DISORDER 320 0.0108
965 BRADYCARDIA 574 0.0108
966 SUICIDAL IDEATION 973 0.0106
967 DISTURBANCE IN ATTENTION 571 0.0106
968 MULTIPLE SCLEROSIS 503 0.0105
969 EYE IRRITATION 581 0.0101
970 IRRITABILITY 600 0.0100
971 HOSPITALISATION 1528 0.0099
972 OVERDOSE 2125 0.0098
973 NIGHTMARE 334 0.0096
974 PRODUCT QUALITY ISSUE 1275 0.0094
975 DYSKINESIA 365 0.0090
976 BLOOD GLUCOSE INCREASED 1643 0.0087
977 AGITATION 600 0.0082
978 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1540 0.0076
979 BLOOD GLUCOSE DECREASED 354 0.0074
980 ACCIDENTAL EXPOSURE TO PRODUCT 746 0.0072
981 SKIN IRRITATION 330 0.0072
982 SKIN BURNING SENSATION 509 0.0071
983 HALLUCINATION 522 0.0069
984 DEATH 5762 0.0067
985 PRODUCT STORAGE ERROR 576 0.0066
986 BLADDER CANCER 383 0.0065
987 NO ADVERSE EVENT 1147 0.0063
988 SUICIDE ATTEMPT 377 0.0062
989 EMOTIONAL DISTRESS 638 0.0053
990 DRUG DEPENDENCE 644 0.0040